Guardant Health GH Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 64.9%+0.4pp | 64.5%+0.7pp | 63.8%+0.9pp | 62.8%+1.5pp | 61.3%+0.6pp | |
| Operating margin | -41.4%+3.1pp | -44.5%+4.5pp | -49%+6.6pp | -55.6%+3.2pp | -58.8%+1.2pp | |
| Net margin | -40.1%+2.3pp | -42.4%+1.8pp | -44.2%+5.7pp | -49.9%+3.9pp | -53.8%+5.2pp | |
| EBITDA margin | -37.8%+2.7pp | -40.5%+4.1pp | -44.6%+6.0pp | -50.6%+2.8pp | -53.4%+0.9pp | |
| Free cash flow margin | -22%+1.8pp | -23.7%+5.3pp | -29.1%+3.7pp | -32.8%+6.6pp | -39.4%-2.2pp | |
| Returns | ||||||
| Return on assets | -26.6%-2.8pp | -23.8%+4.5pp | -28.3%-0.2pp | -28.1%-0.8pp | -27.3%-0.7pp | |
| Return on invested capital | -132.8%-81.0pp | -51.8%— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.1× | 0.6×-0.1× | 0.6×+0.1× | 0.6×+0.1× | 0.5×+0.1× | |
| Inventory turnover | 4.7×+0.3× | 4.4×+0.4× | 4×-0.1× | 4.1×-0.2× | 4.3×-0.1× | |
| Liquidity | ||||||
| Current ratio | 4.7×-0.2× | 4.8×+1.3× | 3.5×-0.2× | 3.7×-0.4× | 4.1×-0.6× | |
| Quick ratio | 4.4×-0.2× | 4.6×+1.4× | 3.1×-0.2× | 3.4×-0.4× | 3.8×-0.6× | |
| Cash ratio | 3.8×+2.2× | 1.6×-1.3× | 2.9×-0.2× | 3.1×-0.5× | 3.6×+0.8× | |
| Leverage | ||||||
| Debt-to-assets | 0.9×0.0× | 0.8×-0.2× | 1×0.0× | 1×0.0× | 1×+0.1× | |
| Interest coverage | -100.5×+11.7× | -112.2×+19.4× | -131.6×+18.7× | -150.3×+16.5× | -166.8×+5.0× | |
| Per Share | ||||||
| Book value per share | -$1.38-74.1% | -$0.79+72.1% | -$2.84-15.4% | -$2.46-21.6% | -$2.02-78.0% | |
| Valuation | ||||||
| Market capitalization | $12.12B-8.7% | $13.27B+70.3% | $7.79B+25.8% | $6.19B+17.8% | $5.26B+39.3% | |
| Enterprise value | $12.72B-12.2% | $14.49B+71.9% | $8.43B+24.1% | $6.79B+17.9% | $5.76B+28.6% | |
| Price / sales | 11.2×-2.3× | 13.5×+4.9× | 8.6×+1.2× | 7.5×+0.7× | 6.8×+1.7× | |
| EV / sales | 11.8×-3.0× | 14.8×+5.4× | 9.3×+1.1× | 8.2×+0.8× | 7.4×+1.4× | |
| Free cash flow yield | -2%-0.2pp | -1.8%+1.6pp | -3.4%+1.0pp | -4.4%+1.4pp | -5.8%+1.5pp | |
| Earnings yield | -3.6%-0.4pp | -3.1%+2.0pp | -5.1%+1.6pp | -6.7%+1.2pp | -7.9%+3.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Guardant Health's profit margins?
- Guardant Health (GH) runs a 64.9% gross margin and a -41.4% operating margin, with a -40.1% net margin.
- Where do Guardant Health's ratios come from?
- Every ratio is computed from Guardant Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
